What the study found
Fourteen healthy younger adults tested seven formulations containing the same stated CoQ10 amount. Blood exposure was followed for 48 hours after each dose, with washouts between conditions. [1]
Formulations differed in exposure, with well-absorbed examples containing either ubiquinone or ubiquinol. Carrier matrices and formulation features mattered, and responses varied substantially between participants. [1]
What remains unanswered
This was an absorption experiment, not a clinical-outcome trial. It cannot rank every current product by redox form alone or show that higher exposure necessarily gives better health outcomes. Funding and conflicts were not established from the abstract. [1]
A hypothetical distinction
Imagine two capsules share a chemical form but use different carriers, while a third uses another form. Attributing every difference to form alone would ignore the other changes in the comparison.
| Detail | Interpretation |
|---|---|
| Seven formulations | More than redox form varied |
| 14 volunteers | Small exposure study |
| Clinical superiority | Not measured |

Sources for this article
- Bioavailability of coenzyme Q10 supplements depends on carrier lipids and solubilization - PubMed
Source consulted: 2026-09-19. This is a reference resource, not a claim that we conducted the studies or tested a product.